Crypto markets showed fresh signs of strain this week as Bitcoin’s rally from last year’s highs runs into what on-chain analysts are calling a liquidity proble Crypto markets showed fresh signs of strain this week as Bitcoin’s rally from last year’s highs runs into what on-chain analysts are calling a liquidity proble

Spot Demand Dries Up as Bitcoin Enters Fifth Month of Correction

3 min read
bitcoin38 main

Crypto markets showed fresh signs of strain this week as Bitcoin’s rally from last year’s highs runs into what on-chain analysts are calling a liquidity problem that has left investors largely on the sidelines. “Spot demand is drying up: Bitcoin enters its 5th month of correction,” posted CryptoQuant, noting that since the violent October event, the market has shed liquidity across futures, stablecoins and spot trading, a combination that helps explain why prices have been so fragile.

The Picture is Stark

CryptoQuant’s team says open interest in derivatives plunged on the October shock, with a single-day drop of more than 70,000 BTC that amounted to roughly $8 billion erased, and that aggregate derivatives commitments have since fallen by roughly 30–31% as leverage was flushed out. That deleveraging, while painful, is the same mechanism that sometimes precedes healthier recoveries, because it removes the fragile leverage that can amplify future crashes. Still, the immediate effect has been lower liquidity and more muted upside for spot buyers.

Spot volumes offer perhaps the clearest warning signal. CryptoQuant’s quicktake shows BTC spot trading volumes have roughly halved since October, with Binance retaining the lion’s share at around $104 billion in the measured window, while competitors such as Gate.io and Bybit sit materially lower. That drop off in active trading, together with stablecoin outflows and a roughly $10 billion decline in stablecoin market cap over the same period, points to an investor base that has grown cautious and capital-constrained.

The price action this week reinforced the narrative. Bitcoin has been trading in the high-$70,000s after a sharp pullback from its October peak; markets were hovering near $78,000 as volatility picked up and traders debated whether the correction had run its course. Analysts phrase it bluntly: the structure is damaged but not irreparably broken, and much depends on whether spot demand returns.

Technically, a number of chart watchers point to the $80,900–$83,000 band as a fragile support zone that has been tested repeatedly; a sustained break below that area could prompt more downside and keep reluctant buyers on the sidelines. Conversely, any convincing resumption of spot volumes would be the clearest signal that genuine demand is re-entering the market, reducing the outsized role of derivatives-driven moves.

Looking ahead, Bitcoin is caught between two problems: a tougher macro backdrop that’s pushing investors into safer assets, and weak on-chain liquidity, think low spot volumes and shrinking stablecoin balances, that needs to recover before people feel comfortable taking bigger risks. Put simply, the charts and on-chain data echo CryptoQuant’s warning: until spot trading and stablecoin flows actually pick up, expect Bitcoin to drift in a fragile, range-bound way, a market that rewards patience more than aggressive bets.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29